Autism Spectrum Risk and Your Genetics

Autism Spectrum Risk is a polygenic trait reflecting how common genetic variants collectively influence susceptibility to autism spectrum disorder (ASD), a neurodevelopmental condition that affects social communication, sensory processing, and behavioral flexibility. Genome-wide association studies across tens of thousands of participants have identified specific chromosomal regions where variants cluster in people with ASD.[¹] This page covers the key genetic signals, what population-scale research has found, and how understanding your genetic profile fits into a broader picture of neurodevelopmental health.

What is Autism Spectrum Risk?

Autism spectrum disorder encompasses a range of neurodevelopmental profiles characterized by differences in social communication, repetitive behaviors, and sensory processing. The word "spectrum" reflects the enormous variation in how these traits express — from individuals who need substantial daily support to those who navigate the world with high independence but notable differences in how they connect with others and process their environment.

Autism is not a single-gene condition. Its genetic architecture is complex, involving contributions from hundreds of common variants each with small individual effects, as well as rarer variants with larger effects in some families. Environmental factors — including prenatal exposures and early developmental context — also play meaningful roles that genetics alone cannot capture.

An Autism Spectrum Risk score from ExomeDNA summarizes your burden of common genetic variants associated with ASD susceptibility. A higher score means your genome carries a greater-than-average concentration of variants linked to elevated susceptibility in population research. It is not a determination of whether a person has or will develop ASD.

The genetics behind Autism Spectrum Risk

The genetic architecture of autism is one of the most intensively studied questions in human genomics. Research has consistently pointed to a combination of common variants with small individual effects and rare variants with larger but less frequent impacts.

Among the most robustly replicated common-variant signals, chromosome 5p14.1 stands out. This region lies between two cadherin genes, CDH9 and CDH10, which encode neuronal cell-adhesion molecules — proteins that guide how brain cells form and maintain connections during development. A landmark genome-wide association study found that the lead variant in this region, rs4307059, reached genome-wide significance with an odds ratio of approximately 1.19, meaning carriers had roughly 19% higher odds of ASD compared to non-carriers.[¹] While modest at the individual level, this signal has been independently replicated and represents the clearest common-variant anchor point for ASD genetics.

A separate GWAS in a predominantly Chinese cohort identified another susceptibility locus on chromosome 1p13.2, implicating the CSDE1 gene region, with replication observed across European-ancestry datasets — suggesting that some genetic risk architecture is shared across human populations.[⁶]

Beyond single loci, research in isolated founder populations has illuminated a complementary layer of risk. A study of autism in the Faroe Islands found that people with ASD carried a higher burden of rare exonic copy-number variants in autism-associated genes and showed greater inbreeding coefficients compared to controls — demonstrating that both polygenic common-variant risk and rare recessive mechanisms contribute to ASD susceptibility in the same population.[⁷]

See our methodology page for how ExomeDNA assesses genetic evidence.

What the research says

Research base: robust.

Multiple independent genome-wide association studies, each analyzing hundreds of thousands to over one million genetic markers across thousands of families, have now confirmed that ASD has a clear and replicable genetic component attributable to common variants.

P = 3.4 × 10⁻⁸, OR ≈ 1.19 The lead variant rs4307059 on chromosome 5p14.1 reached genome-wide significance in a study of 1,204 ASD cases and 6,491 controls, with replication across approximately 11,000 additional subjects.^[¹]

A 2009 genome-wide linkage and association scan across 1,031 multiplex families with 1,553 affected individuals identified a significant association signal on chromosome 5p15, between the SEMA5A and TAS2R1 genes (P = 2 × 10⁻⁷), and found that SEMA5A expression was reduced in brain tissue from autistic individuals — suggesting the variant affects gene regulation in the brain rather than protein structure.[³]

The Autism Genome Project Consortium conducted a GWAS in 1,558 rigorously defined ASD families, genotyping approximately one million SNPs. While the top signal at rs4141463 reached genome-wide significance in the discovery cohort, effect size diminished in replication — a pattern consistent with the statistical winner's curse phenomenon — confirming that most common variants for ASD have genuinely modest effects.[⁴]

Less than 1% of variance Individual common variants each explain less than 1% of variance in ASD risk, yet their collective signal significantly predicts case status across independent samples when aggregated into allele scores.[⁵]

A Stage 2 GWAS involving 2,705 ASD families confirmed this collective-but-modest picture: no single SNP reached genome-wide significance, yet allele scores derived from common variants significantly predicted case status in independent samples. The authors concluded that common variants collectively influence ASD risk, with the top candidate signal in the CNTNAP2 region.[⁵]

Research extending into Arab-ancestry populations using exome-wide association methods identified a high-risk Y-chromosome haplotype in autistic boys (p = 6.85 × 10⁻⁶) alongside candidate susceptibility genes previously implicated in autistic disorder, further underscoring the multi-layered genetic architecture of ASD.[⁸]

Taken together, these findings from hundreds of thousands of participants across multiple ancestries paint a consistent picture: ASD susceptibility is genuinely heritable, distributed across many common variants of small effect, and enriched in specific chromosomal regions involving genes important for brain connectivity and neuronal cell communication.

How Autism Spectrum Risk affects you

Understanding your Autism Spectrum Risk profile is not about receiving a verdict — it is about gaining one more lens through which to understand neurodevelopmental variability.

A higher genetic susceptibility score means your genome carries a greater concentration of common variants that, in large population studies, appear more frequently among people with ASD. This does not translate cleanly into individual outcomes. The majority of people with elevated polygenic scores for ASD do not receive an ASD identification, and many people who are identified with ASD carry average or even below-average polygenic scores, reflecting the contribution of rare variants and non-genetic factors that common-variant analysis does not capture.

Genetic susceptibility scores are most meaningful when understood as one input into a broader picture. If you or a family member have questions about neurodevelopmental differences, behavioral patterns, sensory sensitivities, or social communication styles, genetic information is best interpreted alongside developmental history, behavioral observation, and clinical context provided by qualified professionals.

For families, knowing that ASD has a substantial genetic component can reduce misattribution — helping people understand that autism is a difference in brain development rather than a consequence of parenting choices or environmental exposures within a family's control. Research in multiplex families (those with more than one affected member) has been central to identifying many of the key genetic loci, suggesting that familial clustering is a real genetic phenomenon rather than coincidence.[³]

Working with your Autism Spectrum Risk profile

Your Autism Spectrum Risk genetic profile is most useful as context, not as instruction. Here is how to engage with it thoughtfully.

Understand what the score represents. Your score aggregates dozens to hundreds of common variants, each contributing a small statistical push in the direction of elevated or reduced susceptibility. The score reflects population-level research. It was not derived from your developmental history, your cognitive or sensory profile, or any behavioral assessment.

Consider family context. If autism runs in your family, your genetic score may align with patterns you already recognize. Research in multiplex families has confirmed that shared genetic architecture underlies familial clustering of ASD.[³] Knowing your score can add specificity to what you may already suspect about hereditary patterns.

Use it to inform conversations, not conclusions. For those with questions about neurodevelopmental differences in themselves or their children, bring your genetic data to a conversation with a developmental pediatrician, neuropsychologist, or genetics counselor — professionals who can situate the genetic signal within a full clinical picture.

Recognize the limits of current research. The majority of large GWAS datasets have been collected from European-ancestry populations. For those with non-European ancestry, your score is derived from research that may not fully capture the common-variant architecture relevant to your genome. Studies in Chinese and Arab-ancestry populations have identified overlapping but distinct risk loci,[⁶][⁸] and research representation is an active area of improvement in the field.

Do not use this score to self-identify or rule out ASD. Genetic susceptibility scores are statistical tools, not clinical instruments. Assessment of ASD requires comprehensive developmental evaluation by qualified professionals.

Related traits and genes

Autism spectrum risk does not exist in isolation. Several related neurodevelopmental and behavioral traits share genetic architecture with ASD, and understanding these connections can provide richer context for your results.

ADHD Risk shares substantial genetic overlap with ASD. Both conditions involve differences in attention regulation, sensory processing, and executive function, and they frequently co-occur. Genetic studies have found correlated polygenic signals across the two conditions, though the specific variant architecture differs. See the ADHD Risk trait page for details.

Anxiety Risk is another trait with meaningful co-occurrence alongside ASD. Heightened sensory sensitivity and differences in interoception — the brain's reading of internal body signals — may underlie shared genetic pathways between anxiety susceptibility and ASD. See Anxiety Risk.

Schizophrenia Risk shares certain rare variant regions with ASD, particularly around neuronal connectivity genes. The overlap is not a clinical equivalence but reflects shared neurodevelopmental biology at specific loci. See Schizophrenia Risk.

Among the authorized genes connected to the strongest signals in ASD research, CDH9 encodes a cadherin — a class of calcium-dependent cell-adhesion molecules critical for synapse formation during brain development. The chromosome 5p14.1 region harboring CDH9 and CDH10 represents the most replicated common-variant locus for ASD risk identified to date.[¹] For deeper context on this gene's biological role, see the CDH9 gene page.

Traits with interesting cross-category connections to the neurodevelopmental genetic landscape include Sleep Quality — sleep difficulties are highly prevalent among autistic people and share some neurological substrates — and Pain Sensitivity, which intersects with the sensory processing differences that characterize many autistic experiences.

Frequently asked questions

Is autism caused by genetics alone? No. Autism spectrum disorder arises from a complex interplay of genetic and environmental factors. Research shows that both common variants spread across many chromosomal regions and rarer, higher-impact variants each contribute to overall susceptibility. No single gene or variant fully determines whether a person develops autism.

What chromosomal regions are most strongly linked to autism in GWAS studies? Multiple genome-wide association studies have implicated regions on chromosomes 5p14.1, 5p15, and 1p13.2 as associated with autism spectrum disorder risk. Variants between the CDH9 and CDH10 cadherin genes on 5p14.1 reached genome-wide significance in a landmark 2009 study enrolling over 1,200 cases and 6,400 controls.[¹]

Do common genetic variants have large effects on autism risk individually? No. Research consistently shows that individual common variants each explain less than 1% of variance in autism risk.[⁵] Their collective contribution across many variants is meaningful, but any single variant has a modest effect. This is why polygenic approaches that aggregate many variants are used to assess overall genetic susceptibility.

What does an elevated Autism Spectrum Risk score from ExomeDNA mean? An elevated score reflects that the combination of common genetic variants in your genome is associated with higher statistical susceptibility compared to population averages. It does not mean a person will develop autism, and it is not a clinical assessment. Genetics is one part of a much larger picture that includes development, environment, and individual experience.

Are autism-associated genetic variants found across all ancestries? Most large GWAS studies have focused on European-ancestry populations, but research in Chinese and Arab-ancestry cohorts has identified overlapping and distinct risk loci.[⁶][⁸] Variants on chromosome 1p13.2 were identified in Chinese cohorts and replicated in European datasets, suggesting some shared genetic architecture across ancestries.

Can genetic studies detect all autism risk factors? No. Current GWAS and exome studies capture only a portion of genetic risk. Rare copy-number variants, de novo mutations, and gene-environment interactions each contribute to autism susceptibility in ways that common-variant studies alone do not fully capture. Research in isolated populations has highlighted the additional role of rare homozygous variants.[⁷]

References

[1] Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009;459(7246):528-533. PMID: 19404256.

[2] Ma D, Salyakina D, Jaworski JM, et al. A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann Hum Genet. 2009;73(Pt 3):263-273. PMID: 19456320.

[3] Weiss LA, Arking DE, Daly MJ, Chakravarti A; Gene Discovery Project of Johns Hopkins & the Autism Consortium. A genome-wide linkage and association scan reveals novel loci for autism. Nature. 2009;461(7265):802-808. PMID: 19812673.

[4] Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet. 2010;19(20):4072-82. PMID: 20663923.

[5] Anney R, Klei L, Pinto D, et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Human Molecular Genetics. 2012;21(21):4781-92. PMID: 22843504.

[6] Xia K, Guo H, Hu Z, et al. Common genetic variants on 1p13.2 associate with risk of autism. Molecular Psychiatry. 2014;19(11):1212-1219. PMID: 24189344.

[7] Leblond CS, Cliquet F, Carton C, et al. Both rare and common genetic variants contribute to autism in the Faroe Islands. NPJ Genom Med. 2019;4:1. PMID: 30675382.

[8] Alsubaie LM, Alsuwat HS, Almandil NB, et al. Risk Y-haplotypes and pathogenic variants of Arab-ancestry boys with autism by an exome-wide association study. Mol Biol Rep. 2020;47(10):7623-7632. PMID: 32996047.

Data sources: GWAS Catalog, ClinVar, PheGenI, NCBI Gene, published peer-reviewed literature (PMIDs listed above).

By the ExomeDNA Research Team